Related Experiment Video
Updated: Aug 13, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
Chronic administration of ethanol does not alter plasma kallikrein hepatic clearance
1Departamento de Medicina, Escola Paulista de Medicina, São Paulo, Brasil.
Abstract:
1. The clearance of plasma kallikrein by the isolated and perfused liver of rats chronically intoxicated with ethanol was studied. Alcohol was added to the diet as 36% of total calories, and the animals were kept on this diet for 5-7 weeks. 2. The hepatic clearance of plasma kallikrein by these rats (uptake half-life, 15 +/- 2 min; N = 3) was similar to that observed in the control groups (normal diet, uptake half-life, 14 +/- 2 min; N = 5, or normal diet with sucrose added as 36% of total calories, uptake half-life, 16 +/- 3 min; N = 4). 3. These results provided indirect evidence that the endocytosis mechanism of plasma kallikrein by the liver differs from that described for glycoproteins which use the galactosyl receptor, since liver endocytosis via this latter system is reduced by chronic alcohol intoxication.
More Related Videos
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
Related Concept Videos
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment